Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryHealth Care Supplies
SectorN/A
SymbolNASDAQ:VASC
CUSIP92231M10
Phone+1-763-6564300
Debt
Debt-to-Equity RatioN/A
Current Ratio6.37
Quick Ratio4.66
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins13.02%
Return on Equity15.78%
Return on Assets14.30%
Miscellaneous
Employees568
Outstanding Shares17,570,000
Market Cap$0.00
Vascular Solutions (NASDAQ:VASC) Frequently Asked Questions
What is Vascular Solutions' stock symbol?
Vascular Solutions trades on the NASDAQ under the ticker symbol "VASC."
How were Vascular Solutions' earnings last quarter?
Vascular Solutions, Inc. (NASDAQ:VASC) released its quarterly earnings data on Monday, July, 25th. The medical device company reported $0.33 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.30 by $0.03. The medical device company had revenue of $41.20 million for the quarter, compared to the consensus estimate of $41.40 million. Vascular Solutions had a net margin of 13.02% and a return on equity of 15.78%. The company's quarterly revenue was up 9.7% on a year-over-year basis. During the same period last year, the firm earned $0.29 earnings per share. View Vascular Solutions' Earnings History.
Has Vascular Solutions been receiving favorable news coverage?
Media headlines about VASC stock have been trending somewhat positive recently, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Vascular Solutions earned a news and rumor sentiment score of 0.18 on Accern's scale. They also assigned media headlines about the medical device company an impact score of 47.08 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for Vascular Solutions.
How do I buy shares of Vascular Solutions?
Shares of VASC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Vascular Solutions' stock price today?
One share of VASC stock can currently be purchased for approximately $56.00.
How can I contact Vascular Solutions?
Vascular Solutions' mailing address is 6464 Sycamore Ct N, MAPLE GROVE, MN 55369-6032, United States. The medical device company can be reached via phone at +1-763-6564300.
MarketBeat Community Rating for Vascular Solutions (NASDAQ VASC)
MarketBeat's community ratings are surveys of what our community members think about Vascular Solutions and other stocks. Vote "Outperform" if you believe VASC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VASC will underperform the S&P 500 over the long term. You may vote once every thirty days.
